Search results for "Plasmodium"

showing 10 items of 86 documents

In vitro and in silico studies of polycondensed diazine systems as anti-parasitic agents

2012

Abstract Parasitic diseases caused by protozoarian agents are still relevant today more than ever. Recently, we synthesized several polycondensed diazine derivatives by means 1,3-dipolar cycloaddition reactions. A broad selection of these compounds were submitted to in vitro biological screening against Plasmodium falciparum , Leishmania infantum , Trypanosoma brucei , and Trypanosoma cruzi , resulting active at micromolar level. Induced Fit Docking/MM-GBSA studies were performed giving interesting indications about the probable mechanism of action of the most active compounds

Models MolecularTrypanosoma cruziIn silicoPlasmodium falciparumTrypanosoma brucei bruceiClinical BiochemistryPharmaceutical ScienceTrypanosoma bruceiBiochemistryStructure-Activity Relationshipchemistry.chemical_compoundParasitic Sensitivity Testsparasitic diseasesDrug DiscoveryLeishmania infantumTrypanosoma cruziMolecular BiologyDiazineAntiparasitic AgentsDose-Response Relationship DrugMolecular StructurebiologyOrganic ChemistryPlasmodium falciparumAnti-parasitic Plasmodium Leishmania Trypanosoma Diazine Induced fit docking/MM-GBSAbiology.organism_classificationSettore CHIM/08 - Chimica FarmaceuticaHydrazineschemistryBiochemistryDocking (molecular)TrypanosomaMolecular MedicineLeishmania infantumBioorganic & Medicinal Chemistry Letters
researchProduct

Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization an…

2016

The synthesis and characterization of twenty new pentamethylcyclopentadienyl-rhodium and iridium complexes containing N^N and N^O-chelating chloroquine analogue ligands are described. The in vitro antimalarial activity of the new ligands as well as the complexes was evaluated against the chloroquine sensitive (CQS) NF54 and the chloroquine resistant (CQR) Dd2 strains of Plasmodium falciparum. The antimalarial activity was found to be good to moderate; although all complexes are less active than artesunate, some of the ligands and complexes showed better activity than chloroquine (CQ). In particular, rhodium complexes were found to be considerably more active than iridium complexes against t…

Models Molecularantimalarial propertiesStereochemistryPlasmodium falciparumDrug ResistanceMolecular Conformationchemistry.chemical_elementCrystal structureChemistry Techniques Synthetic010402 general chemistryIridiumLigands01 natural sciencesChlorideRhodiumIridium and Rhodium complexes chloroquine analog ligands Crystal structures in vitro antimalarian activityInorganic Chemistrychemistry.chemical_compoundAntimalarialsmedicineOrganometallic CompoundsMoietyRhodiumIridiumta116iridium complexesGroup 2 organometallic chemistrySchiff basechloroquine analogue ligands010405 organic chemistrypentamethylcyclopentadienyl-rhodium complexesChloroquine0104 chemical scienceschemistryDerivative (chemistry)medicine.drug
researchProduct

Inhibition of Eimeria tenella CDK-related kinase 2: From target identification to lead compounds.

2010

Apicomplexan parasites encompass several human- and animal-pathogenic protozoans such as Plasmodium falciparum, Toxoplasma gondii, and Eimeria tenella. E. tenella causes coccidiosis, a disease that afflicts chickens, leading to tremendous economic losses to the global poultry industry. The considerable increase in drug resistance makes it necessary to develop new therapeutic strategies against this parasite. Cyclin-dependent kinases (CDKs) are key molecules in cell-cycle regulation and are therefore prominent target proteins in parasitic diseases. Bioinformatics analysis revealed four potential CDK-like proteins, of which one—E. tenella CDK-related kinase 2 (EtCRK2)—has already been charact…

Molecular Sequence DataProtozoan ProteinsBiochemistryEimeriaArticleAdenosine TriphosphateCyclin-dependent kinaseDrug Discoveryparasitic diseasesAnimalsHumansComputer SimulationHomology modelingAmino Acid SequenceGeneral Pharmacology Toxicology and PharmaceuticsProtein Kinase InhibitorsPharmacologyVirtual screeningBinding SitesbiologyDrug discoveryKinaseCoccidiosisOrganic ChemistryCyclin-dependent kinase 2Cyclin-Dependent Kinase 2Plasmodium falciparumbiology.organism_classificationMolecular biologyBiochemistrybiology.proteinMolecular MedicineBenzimidazolesChickensSequence AlignmentEimeria tenellaChemMedChem
researchProduct

The IFN-γ-Inducible GTPase, Irga6, Protects Mice against Toxoplasma gondii but Not against Plasmodium berghei and Some Other Intracellular Pathogens

2011

Clearance of infection with intracellular pathogens in mice involves interferon-regulated GTPases of the IRG protein family. Experiments with mice genetically deficient in members of this family such as Irgm1(LRG-47), Irgm3(IGTP), and Irgd(IRG-47) has revealed a critical role in microbial clearance, especially for Toxoplasma gondii. The in vivo role of another member of this family, Irga6 (IIGP, IIGP1) has been studied in less detail. We investigated the susceptibility of two independently generated mouse strains deficient in Irga6 to in vivo infection with T. gondii, Mycobacterium tuberculosis, Leishmania mexicana, L. major, Listeria monocytogenes, Anaplasma phagocytophilum and Plasmodium …

Naturwissenschaftliche Fakultät -ohne weitere Spezifikation-Plasmodium bergheiScience-medicine.disease_causeMicrobiologyLeishmania mexicanaGTP PhosphohydrolasesMicrobiologyMiceListeria monocytogenesIn vivoddc:570Parasite Groupsparasitic diseasesmedicineAnimalsLeishmania majorPlasmodium bergheiBiologyMicrobial PathogensPathogenMultidisciplinarybiologyIntracellular parasiteQRImmunityToxoplasma gondiiImmune DefenseMacrophage Activationbiology.organism_classificationVirologyInnate ImmunityBacterial PathogensHost-Pathogen InteractionMice Inbred C57BLMedicineParasitologyToxoplasmaToxoplasmosisResearch ArticlePLoS ONE
researchProduct

Transfusion‐transmitted malaria of plasmodium malariae in palermo, sicily

2021

Transfusion-transmitted malaria (TTM) is a rare occurrence with serious consequences for the recipient. In non-endemic areas, the incidence of transmission of malaria by transfusion is very low. We report a clinical case of transfusion-transmitted malaria due to Plasmodium malariae, which happened in a patient with acute hemorrhagic gastropathy. Case presentation: In April 2019, a 70-year-old Italian man with recurrent spiking fever for four days was diagnosed with a P. malariae infection, as confirmed using microscopy and real-time PCR. The patient had never been abroad, but about two months before, he had received a red blood cell transfusion for anemia. Regarding the donor, we revealed t…

Pediatricsmedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaBlood transfusionLeadership and ManagementAnemiamedicine.medical_treatmentmalariaCase ReportthrombocytopeniaHealth InformaticsPlasmodium malariaeParasitemiablood transfusionblood donor screeningAsymptomaticPlasmodium malariaetransfusion-transmitted malariaHealth Information ManagementAsymptomatic semi‐immune donors Blood donor screening Blood transfusion Malaria Plasmodium malariae Thrombocytopenia Transfusion-transmitted malaria<i>Plasmodium malariae</i>parasitic diseasesmedicinebiologybusiness.industryHealth PolicyIncidence (epidemiology)Rbiology.organism_classificationmedicine.diseaseDiagnosis of malariaasymptomatic semi-immune donorsMedicinemedicine.symptombusinessMalaria
researchProduct

2019

Phytochemical investigations of ethanol root bark and stem bark extracts of Cleistochlamys kirkii (Benth.) Oliv. (Annonaceae) yielded a new benzopyranyl cadinane-type sesquiterpene (cleistonol, 1) alongside 12 known compounds (2–13). The structures of the isolated compounds were established from NMR spectroscopic and mass spectrometric analyses. Structures of compounds 5 and 10 were further confirmed by single crystal X-ray crystallographic analyses, which also established their absolute stereochemical configuration. The ethanolic crude extract of C. kirkii root bark gave 72% inhibition against the chloroquine-sensitive 3D7-strain malaria parasite Plasmodium falciparum at 0.01 μg/mL. The is…

Pharmaceutical ScienceSesquiterpene01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundDrug DiscoveryCytotoxic T cellPhysical and Theoretical ChemistryCytotoxicityIC50biologyTraditional medicine010405 organic chemistryOrganic ChemistryPlasmodium falciparumbiology.organism_classification0104 chemical sciences010404 medicinal & biomolecular chemistrychemistryPhytochemicalChemistry (miscellaneous)Annonaceaevisual_artvisual_art.visual_art_mediumMolecular MedicineBarkMolecules
researchProduct

Discovery of new antimalarial compounds by use of molecular connectivity techniques.

1999

Abstract Molecular connectivity has been applied to the search for new compounds with antimalarial activity. Linear discriminant analysis and connectivity functions were used to select several potentially suitable drugs which were tested for antimalarial properties by use of an in-vitro micro test which estimates parasite growth by measurement of incorporation of [3H]hypoxanthine. Hexetidine stands out among the compounds selected. Activity assays were performed with Plasmodium falciparum passou and 3CD7 strains, for which the IC50 values (doses resulting in 50% inhibition) were 320 and 400 ng mL−1 respectively. These results are comparable with those obtained for quinine chlorhydrate (IC50…

PharmacologyDrugQuininebiologyStereochemistrymedia_common.quotation_subjectPlasmodium falciparumPharmaceutical SciencePlasmodium falciparumBiological activityHexetidineChloroquine sulphatebiology.organism_classificationchemistry.chemical_compoundAntimalarialsBiochemistrychemistryDrug DesignmedicineAnimalsHumansIC50Hypoxanthinemedicine.drugmedia_commonThe Journal of pharmacy and pharmacology
researchProduct

Dioncophyllines C2, D2, and F and related naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus ileboensis with potent activities ag…

2017

Dioncophylline F (1), the first 5,8'-coupled dioncophyllaceous alkaloid (i.e., lacking an oxygen function at C-6 and possessing an R-configuration at C-3), was isolated from the recently described Congolese liana Ancistrocladus ileboensis. Two further, likewise Dioncophyllaceae-type, alkaloids, the dioncophyllines C2 (2) and D2 (3), were identified, along with the Ancistrocladaceae-type compound ancistrocladisine B (4), which is oxygenated at C-6 and S-configured at C-3. The structures of the new compounds were determined by spectroscopic, chemical, and chiroptical methods. The stereostructure of 1 was further confirmed by total synthesis. As a consequence of the lack of a methyl group orth…

Pharmacologybiology010405 organic chemistryStereochemistryAlkaloidOrganic ChemistryPharmaceutical ScienceTotal synthesisPlasmodium falciparum010402 general chemistrybiology.organism_classification01 natural sciencesLeukemia cell line0104 chemical sciencesAnalytical ChemistryAncistrocladus ileboensischemistry.chemical_compoundComplementary and alternative medicineLianachemistryDrug DiscoveryMolecular MedicineAncistrocladaceaeMethyl group
researchProduct

Prenylated Flavonoids from the Roots of Tephrosia rhodesica

2020

Five new compounds—rhodimer (1), rhodiflavan A (2), rhodiflavan B (3), rhodiflavan C (4), and rhodacarpin (5)—along with 16 known secondary metabolites, were isolated from the CH2Cl2–CH3OH (1:1) extract of the roots of Tephrosia rhodesica. They were identified by NMR spectroscopic, mass spectrometric, X-ray crystallographic, and ECD spectroscopic analyses. The crude extract and the isolated compounds 2–5, 9, 15, and 21 showed activity (100% at 10 μg and IC50 = 5–15 μM) against the chloroquine-sensitive (3D7) strain of Plasmodium falciparum. peerReviewed

Plasmodium falciparumPharmaceutical Sciencemolecular structurehernekasvitCrystallography X-Ray01 natural sciencesPlant RootsArticleAnalytical ChemistryAntimalarialsflavonoiditPrenylationDrug DiscoveryBiological sciencesBiologynuclear magnetic resonance spectroscopyPharmacologyFlavonoidsPrenylationantimikrobiset yhdisteetOrganisk kemiChromatographybiologyStrain (chemistry)Molecular Structure010405 organic chemistryTephrosiaChemistrySpectrum AnalysisPharmacology. TherapycarbonOrganic ChemistryPlasmodium falciparumbiology.organism_classificationcircular dichroism spectroscopyluonnonaineetMass spectrometric0104 chemical sciences010404 medicinal & biomolecular chemistryChemistryComplementary and alternative medicineTephrosiaMolecular MedicineSpectrum analysismetabolism
researchProduct

Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine

2022

We described a case of clinical reactivation of chronic P. malariae infection following CoVID-19 vaccination with BNT162b2 (Pifzer-Biontech CoVID-19 vaccine) in a 48-year old Italian man.The patient came to our attention for fever of unknown origin show a quartan pattern (every third day) associated to splenomegaly, the onset of the fever occurred one month after CoVID-19 vaccination with BNT162b2. P. malariae was diagnosed using CarestartTM malaria rapid test and Polymerase-Chain Reaction. Post-vaccine transient reduction of immune reactivity is described in literature, although the mechanism is unknown.(c) 2022 Published by Elsevier Ltd.CC_BY_NC_ND_4.0

Plasmodium malariaeInfectious DiseasesPlasmodium malariae.BNT162b2Chronic malariaBNT162b2; Chronic malaria; CoVID-19 vaccine; Malaria; Plasmodium malariaeCoVID-19 vaccineMalariaIDCases
researchProduct